Drug
Gsk961081 SD
Gsk961081 SD: highest development phase Phase 1, developed by Theravance Biopharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Theravance Biopharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| GSK961081 15mcg SD NCT00887406 | Phase 1 | Pulmonary Disease, Chronic Obstructive |
Latest
No recent events.
Follow Gsk961081 SD on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.